318 related articles for article (PubMed ID: 32891234)
1. Financial incentives to promote retention in care and viral suppression in adults with HIV initiating antiretroviral therapy in Tanzania: a three-arm randomised controlled trial.
Fahey CA; Njau PF; Katabaro E; Mfaume RS; Ulenga N; Mwenda N; Bradshaw PT; Dow WH; Padian NS; Jewell NP; McCoy SI
Lancet HIV; 2020 Nov; 7(11):e762-e771. PubMed ID: 32891234
[TBL] [Abstract][Full Text] [Related]
2. Financial incentives for achieving and maintaining viral suppression among HIV-positive adults in Uganda: a randomised controlled trial.
Thirumurthy H; Ndyabakira A; Marson K; Emperador D; Kamya M; Havlir D; Kwarisiima D; Chamie G
Lancet HIV; 2019 Mar; 6(3):e155-e163. PubMed ID: 30660594
[TBL] [Abstract][Full Text] [Related]
3. Preparing a financial incentive program to improve retention in HIV care and viral suppression for scale: using an implementation science framework to evaluate an mHealth system in Tanzania.
Packel L; Fahey C; Kalinjila A; Mnyippembe A; Njau P; McCoy SI
Implement Sci Commun; 2021 Sep; 2(1):109. PubMed ID: 34556176
[TBL] [Abstract][Full Text] [Related]
4. Financial Incentives for Linkage to Care and Viral Suppression Among HIV-Positive Patients: A Randomized Clinical Trial (HPTN 065).
El-Sadr WM; Donnell D; Beauchamp G; Hall HI; Torian LV; Zingman B; Lum G; Kharfen M; Elion R; Leider J; Gordin FM; Elharrar V; Burns D; Zerbe A; Gamble T; Branson B;
JAMA Intern Med; 2017 Aug; 177(8):1083-1092. PubMed ID: 28628702
[TBL] [Abstract][Full Text] [Related]
5. Adherence clubs and decentralized medication delivery to support patient retention and sustained viral suppression in care: Results from a cluster-randomized evaluation of differentiated ART delivery models in South Africa.
Fox MP; Pascoe S; Huber AN; Murphy J; Phokojoe M; Gorgens M; Rosen S; Wilson D; Pillay Y; Fraser-Hurt N
PLoS Med; 2019 Jul; 16(7):e1002874. PubMed ID: 31335865
[TBL] [Abstract][Full Text] [Related]
6. Durability of effects from short-term economic incentives for clinic attendance among HIV positive adults in Tanzania: long-term follow-up of a randomised controlled trial.
Fahey CA; Njau PF; Kelly NK; Mfaume RS; Bradshaw PT; Dow WH; McCoy SI
BMJ Glob Health; 2021 Dec; 6(12):. PubMed ID: 34952856
[TBL] [Abstract][Full Text] [Related]
7. Financial incentives for reduced alcohol use and increased isoniazid adherence during tuberculosis preventive therapy among people with HIV in Uganda: an open-label, factorial randomised controlled trial.
Chamie G; Hahn JA; Kekibiina A; Emenyonu NI; Beesiga B; Marson K; Fatch R; Lodi S; Adong J; Thirumurthy H; McDonell MG; Gandhi M; Bryant K; Havlir DV; Kamya MR; Muyindike WR
Lancet Glob Health; 2023 Dec; 11(12):e1899-e1910. PubMed ID: 37973340
[TBL] [Abstract][Full Text] [Related]
8. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial.
Lester RT; Ritvo P; Mills EJ; Kariri A; Karanja S; Chung MH; Jack W; Habyarimana J; Sadatsafavi M; Najafzadeh M; Marra CA; Estambale B; Ngugi E; Ball TB; Thabane L; Gelmon LJ; Kimani J; Ackers M; Plummer FA
Lancet; 2010 Nov; 376(9755):1838-45. PubMed ID: 21071074
[TBL] [Abstract][Full Text] [Related]
9. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.
Ciaffi L; Koulla-Shiro S; Sawadogo AB; Ndour CT; Eymard-Duvernay S; Mbouyap PR; Ayangma L; Zoungrana J; Gueye NFN; Diallo M; Izard S; Bado G; Kane CT; Aghokeng AF; Peeters M; Girard PM; Le Moing V; Reynes J; Delaporte E;
Lancet HIV; 2017 Sep; 4(9):e384-e392. PubMed ID: 28566227
[TBL] [Abstract][Full Text] [Related]
10. Conditional economic incentives and motivational interviewing to improve adolescents' retention in HIV care and adherence to antiretroviral therapy in Southeast Nigeria: study protocol for a cluster randomised trial.
Ekwunife OI; Anetoh MU; Kalu SO; Ele PU; Eleje GU
Trials; 2018 Dec; 19(1):710. PubMed ID: 30594223
[TBL] [Abstract][Full Text] [Related]
11. Point-of-care HIV viral load testing combined with task shifting to improve treatment outcomes (STREAM): findings from an open-label, non-inferiority, randomised controlled trial.
Drain PK; Dorward J; Violette LR; Quame-Amaglo J; Thomas KK; Samsunder N; Ngobese H; Mlisana K; Moodley P; Donnell D; Barnabas RV; Naidoo K; Abdool Karim SS; Celum C; Garrett N
Lancet HIV; 2020 Apr; 7(4):e229-e237. PubMed ID: 32105625
[TBL] [Abstract][Full Text] [Related]
12. Rudi Kundini, Pamoja Kundini (RKPK): study protocol for a hybrid type 1 randomized effectiveness-implementation trial using data science and economic incentive strategies to strengthen the continuity of care among people living with HIV in Tanzania.
Kadota JL; Packel LJ; Mlowe M; Ulenga N; Mwenda N; Njau PF; Dow WH; Wang J; Sabasaba A; McCoy SI
Trials; 2024 Feb; 25(1):114. PubMed ID: 38336793
[TBL] [Abstract][Full Text] [Related]
13. Voucher incentives to improve viral suppression among HIV-positive people who inject drugs and men who have sex with men in India: a cluster randomised trial.
Solomon SS; McFall AM; Srikrishnan AK; Verma V; Anand S; Khan RT; Kushwaha BS; Vasudevan C; Saravanan S; Paneerselvam N; Kumar MS; Das C; Celentano DD; Mehta SH; Lucas GM
Lancet HIV; 2024 May; 11(5):e309-e320. PubMed ID: 38583461
[TBL] [Abstract][Full Text] [Related]
14. Uptake of antiretroviral therapy and male circumcision after community-based HIV testing and strategies for linkage to care versus standard clinic referral: a multisite, open-label, randomised controlled trial in South Africa and Uganda.
Barnabas RV; van Rooyen H; Tumwesigye E; Brantley J; Baeten JM; van Heerden A; Turyamureeba B; Joseph P; Krows M; Thomas KK; Schaafsma TT; Hughes JP; Celum C
Lancet HIV; 2016 May; 3(5):e212-20. PubMed ID: 27126488
[TBL] [Abstract][Full Text] [Related]
15. A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy study.
Miller WC; Hoffman IF; Hanscom BS; Ha TV; Dumchev K; Djoerban Z; Rose SM; Latkin CA; Metzger DS; Lancaster KE; Go VF; Dvoriak S; Mollan KR; Reifeis SA; Piwowar-Manning EM; Richardson P; Hudgens MG; Hamilton EL; Sugarman J; Eshleman SH; Susami H; Chu VA; Djauzi S; Kiriazova T; Bui DD; Strathdee SA; Burns DN
Lancet; 2018 Sep; 392(10149):747-759. PubMed ID: 30191830
[TBL] [Abstract][Full Text] [Related]
16. Behavioral Economic Incentives to Support HIV Care: Results From a Randomized Controlled Trial in Uganda.
Linnemayr S; Wagner Z; Saya UY; Stecher C; Lunkuse L; Wabukala P; Odiit M; Mukasa B
J Acquir Immune Defic Syndr; 2024 Jul; 96(3):250-258. PubMed ID: 38534162
[TBL] [Abstract][Full Text] [Related]
17. Rudi Kundini, Pamoja Kundini (RKPK): study protocol for a hybrid type 1 randomized effectiveness-implementation trial using data science and economic incentive strategies to strengthen the continuity of care among people living with HIV in Tanzania.
Kadota JL; Packel LJ; Mlowe M; Ulenga N; Mwenda N; Njau PF; Dow WH; Wang J; Sabasaba A; McCoy SI
Res Sq; 2023 Dec; ():. PubMed ID: 38196655
[TBL] [Abstract][Full Text] [Related]
18. The impact of cash incentives on mental health among adults initiating antiretroviral therapy in Tanzania.
Sheira LA; Ryan KP; Fahey CA; Katabaro ED; Sabasaba AN; Njau PF; McCoy SI
AIDS Care; 2024 Feb; 36(2):195-203. PubMed ID: 37321981
[TBL] [Abstract][Full Text] [Related]
19. A commitment contract to achieve virologic suppression in poorly adherent patients with HIV/AIDS.
Alsan M; Beshears J; Armstrong WS; Choi JJ; Madrian BC; Nguyen MLT; Del Rio C; Laibson D; Marconi VC
AIDS; 2017 Jul; 31(12):1765-1769. PubMed ID: 28514277
[TBL] [Abstract][Full Text] [Related]
20. Effects of incentives on viral suppression in people living with HIV who use cocaine or opiates.
Pollock S; Toegel F; Holtyn AF; Rodewald AM; Leoutsakos JM; Fingerhood M; Silverman K
Drug Alcohol Depend; 2020 Jul; 212():108000. PubMed ID: 32362436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]